A synopsis of a couple of late analyst calls that could buoy these small cap biotech stocks in trading tomorrow
Free report on an immunotherapy play Fate Therapeutics (FATE)
A synopsis of recent analyst activity that could buoy these small cap biotech stocks in trading today
$MYL $TBPH An Updated Investment View On Theravance Biopharma
$XBI 4 Notable Early Analyst Calls
We provided a 'deep dive' on Geron last week to Biotech Forum subscribers. We passed on recommendation and advise Forum…
Nano cap Isoray (ISR) gets a rare 'shout out' from an analyst firm after recent earnings. Maxim Group reissues their…
Amarin Corp. (AMRN) have good reasons to smile this morning.
Bret Jensen: In my three decades of investing, I have found that the only way to significantly outperform the market is…
"Leap has strategic partnerships and upcoming catalysts. The company also has multiple "shots on goal" and is picking up…
$IMDZ Immune Design: Can This Small Oncology Play Deliver?
